Ophtholique® (Drops) Instructions for Use
ATC Code
S01XA (Other preparations for the treatment of eye diseases)
Active Substances
Povidone (Rec.INN registered by WHO)
Polyvinyl alcohol (USP United States Pharmacopeia)
Clinical-Pharmacological Group
Drug for moisturizing and protecting the cornea
Pharmacotherapeutic Group
Keratoprotector
Pharmacological Action
A combined medicinal product for topical use in ophthalmology, a keratoprotector. It has a protective effect on the cornea in cases of decreased tear fluid secretion or increased tear film evaporation.
Polyvinyl alcohol and povidone have lubricant properties, which reduce eye irritation and redness. By coating the eye surface, these substances reduce surface tension and prevent the occurrence of tear film ruptures.
Polyvinyl alcohol has properties similar to those of mucin produced by the conjunctival glands. It helps to soften and lubricate (moisturize) the eye surface and increases the stability of the tear film.
Pharmacokinetics
The systemic absorption of the active substances from the eye surface is minimal. After instillation into each eye, the concentration of the drug’s active substances in plasma after 4 hours remains below the possible limit of quantitation (10 ng/ml).
Indications
Use for the relief of symptoms associated with ocular surface dryness.
- Sensation of burning, irritation, and discomfort caused by dry eye.
- As tear substitutes in conditions of decreased tear fluid secretion.
- Dry eye syndrome.
- Other conditions requiring softening and/or moisturizing of the cornea.
Apply as a protective and lubricating agent for the ocular surface.
ICD codes
| ICD-10 code | Indication |
| H04.1 | Other disorders of lacrimal gland (dry eye syndrome) |
| H19.3 | Keratitis and keratoconjunctivitis in diseases classified elsewhere (dry keratoconjunctivitis) |
| ICD-11 code | Indication |
| 9A1Z | Diseases of the lacrimal system, unspecified |
| 9A75 | Autoimmune keratitis |
| 9A7Z | Diseases of the cornea, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Instill one drop into the conjunctival sac of each eye, three to four times daily.
Adjust the frequency of administration based on the severity of symptoms and individual patient needs.
Ensure the dropper tip does not contact the eye or any other surface to prevent contamination.
Adverse Reactions
Adverse reactions are typically mild and transient.
Discontinue use immediately and consult a healthcare professional if signs of an allergic reaction occur, such as ocular or eyelid redness, itching, swelling, or rash.
Temporary blurred vision or eye discomfort may occur immediately after instillation.
Contraindications
Do not use in patients with a known hypersensitivity to any component of the formulation.
- Hypersensitivity to povidone.
- Hypersensitivity to polyvinyl alcohol.
- Hypersensitivity to any of the excipients.
Avoid use if there is a history of severe allergic reactions to the product.
Use in Pregnancy and Lactation
There is insufficient experience with the use of this combination during pregnancy and lactation.
Use during pregnancy and lactation (breastfeeding) is possible only if the intended benefit to the mother outweighs the potential risk to the fetus.
Special Precautions
The patient should discontinue use and consult a doctor if, during use, the pain intensifies; vision deteriorates; symptoms persist for more than 72 hours; redness and irritation of the eyes persist.
Drug Interactions
Apply other ophthalmic medications at least 15 minutes before instilling these drops to avoid dilution and potential interaction.
Polyvinyl alcohol is incompatible with inorganic salts, particularly phosphates and sulfates, which may cause precipitation.
Povidone may form complexes and reduce the effectiveness of certain preservatives, such as thimerosal.
Overdose
Ocular overdose is unlikely due to the topical administration and minimal systemic absorption.
In case of accidental ingestion, symptomatic and supportive measures are recommended.
Excessive topical application may lead to temporary visual blurring or eye discomfort; rinse the eye with clean water if this occurs.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Eye drops 14 mg+6 mg/1 ml: 10 ml dropper bottle
Marketing Authorization Holder
Sentiss Pharma, Pvt. Ltd. (India)
Dosage Form
| Ophtholique® | Eye drops 14 mg+6 mg/1 ml: 10 ml dropper bottle |
Dosage Form, Packaging, and Composition
Eye drops as a transparent, colorless or slightly yellowish solution.
| 1 ml | |
| Polyvinyl alcohol | 14 mg |
| Povidone | 6 mg |
Excipients: benzalkonium chloride – 0.1 mg, disodium edetate – 1 mg, sodium chloride – 8.4 mg, water for injections – 1 ml.
10 ml – plastic dropper bottles (1) – cardboard packs.
Eye drops 14 mg+6 mg/1 ml: 0.4 ml dropper tubes, 5, 10, 20, or 30 pcs.
Marketing Authorization Holder
Sentiss Pharma, Pvt. Ltd. (India)
Dosage Form
| Ophtholique® BK | Eye drops 14 mg+6 mg/1 ml: 0.4 ml dropper tubes, 5, 10, 20, or 30 pcs. |
Dosage Form, Packaging, and Composition
Eye drops (preservative-free) as a transparent solution from colorless to light yellow.
| 1 ml | |
| Polyvinyl alcohol | 14 mg |
| Povidone | 6 mg |
Excipients: disodium edetate – 1 mg, sodium chloride – 8.46 mg, sodium hydroxide – q.s., hydrochloric acid – q.s., water for injections – q.s. to 1 ml.
0.4 ml – dropper tubes (5) – plastic cartridges (1) – laminated foil bags (1) – cardboard packs.
0.4 ml – dropper tubes (5) – plastic cartridges (1) – laminated foil bags (2) – cardboard packs.
0.4 ml – dropper tubes (5) – plastic cartridges (1) – laminated foil bags (4) – cardboard packs.
0.4 ml – dropper tubes (5) – plastic cartridges (1) – laminated foil bags (6) – cardboard packs.
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Kagocel pills 12mg, 30pcs
Picamilon pills 50mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Ingavirin capsules 90mg, 10pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Noopept, pills 10mg, 50pcs 